4.5 Review

Intrahepatic cholestasis of pregnancy and maternal dyslipidemia: a systematic review and meta-analysis

Journal

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
Volume 101, Issue 7, Pages 719-727

Publisher

WILEY
DOI: 10.1111/aogs.14380

Keywords

cholesterol; dyslipidemia; intrahepatic cholestasis of pregnancy; lipid; triglycerides

Funding

  1. National Natural Science Foundation of China [81571446]
  2. National Natural Science Foundation for Young Scientists of China [82001560]

Ask authors/readers for more resources

This systematic review and meta-analysis aimed to evaluate the association between intrahepatic cholestasis of pregnancy (ICP) and maternal lipid metabolism. The results showed a significant association between ICP and maternal dyslipidemia, indicating that ICP pregnancies have dysregulated lipid metabolism compared to normal pregnancies.
Introduction The association between intrahepatic cholestasis of pregnancy (ICP) and maternal lipid metabolism remains unknown. This systematic review and meta-analysis aimed to evaluate the association between ICP and maternal lipid metabolism. Material and methods We systematically searched Medline, Embase and the Cochrane Library (up to December 11, 2021) to identify relevant studies that investigated ICP and maternal plasma lipid concentrations. The weighted mean difference (WMD) and 95% confidence intervals (CI) were calculated using random-effects models. A subgroup analysis was conducted to identify the potential sources of heterogeneity. Potential publication bias was tested using funnel plots and the Egger's and Begg's tests. This meta-analysis was registered with PROSPERO (CRD42021293783). Results Eleven studies were included in this qualitative analysis. A random-effects meta-analysis of data from the final included nine studies (n = 786 participants) showed a significant association between ICP and maternal dyslipidemia, with elevated levels of triglycerides (WMD, 0.67 mmol/L; 95% CI 0.39-0.95; P < 0.001), total cholesterol (WMD, 1.08 mmol/L; 95% CI 0.58-1.58; P < 0.001), low-density lipoprotein cholesterol (WMD, 1.08 mmol/L; 95% CI 0.53-1.64; P < 0.001), and reduced high-density lipoprotein cholesterol level (WMD, -0.38 mmol/L; 95% CI -0.53 to -0.23; P < 0.001) vs normal pregnancies. Conclusions The present study's findings support an association between ICP and maternal dyslipidemia. ICP pregnancies have dysregulated lipid metabolism vs normal pregnancies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available